Sirona Competitors

Stocks . Canada . 
Stock . Sirona Biochem Corp
SBM Stock  CAD 0.07  0.01  8.33%   
Sirona Biochem Corp competes with DelphX Capital, Citadel Income, Crown Capital, IShares Canadian, and PHN Multi; as well as few others. The company classifies itself under Biotechnology sector and is part of Health Care industry. Analyzing Sirona Biochem competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Sirona Biochem to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Sirona Biochem Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Sirona Biochem competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
0.000.0515.98
Details
Intrinsic
Valuation
LowRealHigh
0.000.0515.98
Details

Sirona Biochem Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Sirona Biochem and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Sirona and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Sirona Biochem Corp does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ULV-U
+ 0.91
XHB
0P0000OXA6
+ 0.89
CTF-UN
EDGF
+ 0.79
CTF-UN
EDGF
+ 0.79
XHB
ULV-U
+ 0.78
EDGF
ULV-U
+ 0.77
CTF-UN
  
High negative correlations   
CRWN
- 0.63
DELX
EDGF
- 0.61
CRWN
XHB
- 0.56
CRWN
ULV-U
- 0.55
CRWN
0P0000OXA6
- 0.49
CRWN
ULV-U
- 0.44
SOLR

Risk-Adjusted Indicators

There is a big difference between Sirona Stock performing well and Sirona Biochem Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sirona Biochem's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DELX  7.79  1.28  0.11  1.08  7.81 
(11.64)
 18.18 
(15.00)
 53.36 
CTF-UN  0.90  0.13  0.07  1.23  0.75 
(1.64)
 3.08 
(1.87)
 6.35 
CRWN  5.29 (0.68) 0.00 (1.05) 0.00 
 0.00 
 15.97 
(22.22)
 60.46 
ZUAG-U  0.15  0.00 (0.08)(0.05) 0.27 
(0.37)
 0.46 
(0.46)
 3.34 
TNO-H  14.58  4.23  0.00 (0.46) 0.00 
 0.00 
 100.00 
(50.00)
 150.00 
XHB  0.20  0.02 (0.14)(0.53) 0.09 
(0.26)
 0.47 
(0.31)
 0.97 
EDGF  0.85  0.03  0.00  0.13  1.16 
(1.15)
 2.13 
(2.76)
 6.96 
SOLR  5.90  0.07  0.00 (0.02) 8.12 
(24.37)
 25.00 
(20.00)
 45.00 
0P0000OXA6  0.61  0.06  0.00 (5.19) 0.85 
(0.59)
 1.24 
(1.56)
 3.72 
ULV-U  0.22  0.09  0.00  7.80  0.00 
 0.00 
 0.46 
 0.00 
 5.13 

Cross Equities Net Income Analysis

Compare Sirona Biochem Corp and related stocks such as DelphX Capital Markets, Citadel Income, and Crown Capital Partners Net Income Over Time
201020112012201320142015201620172018201920202021202220232024
DELX(1.5 M)(1.5 M)(1.5 M)(1.5 M)(1.5 M)(1.5 M)(1.5 M)(169.9 K)(8.5 M)(4.9 M)(2.6 M)(3.3 M)(4.7 M)(2 M)(2.1 M)
CRWN3343343341.5 K1.9 K2 M5.1 M6.7 M7.1 M5.8 M203 K8.1 M(9 M)(12.2 M)(11.5 M)
TNO-H(553.6 K)(553.6 K)(553.6 K)(553.6 K)(70.2 K)56.7 K(1 M)(331.9 K)(580.8 K)(368.6 K)(611.9 K)(372 K)(560.2 K)(296.1 K)(310.9 K)
SOLR(43.6 K)(3.2 M)(11.3 M)(9.9 M)13.3 M5.5 M(3.2 M)(7.5 M)(2.3 M)(2.8 M)(1.4 M)(448.9 K)(2.7 M)(1.8 M)(1.9 M)

Sirona Biochem Corp and related stocks such as DelphX Capital Markets, Citadel Income, and Crown Capital Partners Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Sirona Biochem Corp financial statement analysis. It represents the amount of money remaining after all of Sirona Biochem Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Sirona Biochem Competitive Analysis

The better you understand Sirona Biochem competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Sirona Biochem's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Sirona Biochem's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SBM DELX CTF-UN CRWN ZUAG-U TNO-H XHB EDGF SOLR 0P0000OXA6
 8.33 
 0.07 
Sirona
 14.29 
 0.12 
DelphX
 0.37 
 2.67 
Citadel
 3.64 
 1.06 
Crown
 0.03 
 30.15 
BMO
 50.00 
 0.01 
Terreno
 0.26 
 19.63 
IShares
 2.37 
 10.80 
Brompton
 20.00 
 0.04 
Solar
 1.56 
 27.11 
PHN
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Slightly risky
Out of control
Very steady
Out of control
Very steady
Not too volatile
Out of control
Very steady
Market Performance
(90 Days Performance)
Good
OK
Good
Very Weak
Very Weak
OK
OK
OK
Weak
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Average
Low
Very High
About Average
Below Average
Low
About Average
Very High
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Sell
Strong Sell
Strong Hold
Strong Sell
Sell
Strong Sell
Cautious Hold
Cautious Hold
Strong Sell
Sell
Current Ratio
0.98
0.18
165.78
37.15
N/A
0.19
N/A
N/A
0.19
N/A
Net Asset
1.03 M
237.08 K
N/A
176.65 M
N/A
47.81 K
430.05 M
N/A
1.8 M
5.64 B
Profit Margin
N/A
N/A
N/A
-0.47
N/A
N/A
N/A
N/A
-0.0107
N/A
EBITDA
(2.26 M)
(4.49 M)
N/A
7.46 M
N/A
(598.28 K)
N/A
N/A
(762.93 K)
N/A
Operating Margin
-258.82
270.88
131.28
58.07
N/A
N/A
N/A
N/A
-0.7
N/A
Current Valuation
20.11 M
25.32 M
(11.41 M)
103.89 M
N/A
612.51 K
N/A
N/A
11.84 M
N/A
Price To Book
41.64
25.82
0.8
0.26
N/A
32.57
N/A
N/A
93.97
N/A
Retained Earnings
(43.9 M)
(34.63 M)
N/A
(25.42 M)
N/A
(13.18 M)
N/A
N/A
(68.87 M)
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
2.7
N/A
N/A
8.42
One Year Return
N/A
N/A
N/A
N/A
N/A
N/A
13.8
N/A
N/A
-0.8
Beta
-0.027
0.8
0.68
0.68
N/A
3.9
0.95
0.97
1.33
N/A
Number Of Employees
N/A
N/A
N/A
7
N/A
N/A
1
N/A
N/A
N/A
Cash Position Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.58
Equity Positions Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
98.42
Shares Outstanding
258.84 M
181.67 M
15.16 M
5.59 M
N/A
64.17 M
N/A
N/A
294.19 M
N/A
Three Year Return
N/A
N/A
N/A
N/A
N/A
N/A
2.0
N/A
N/A
5.68
Cash Flow From Operations
(1.76 M)
(2.01 M)
17.66 M
17.04 M
N/A
(129.41 K)
N/A
N/A
97.33 K
N/A
Total Debt
637.65 K
2.6 M
N/A
81.66 M
N/A
714.78 K
N/A
N/A
137.5 K
N/A
Return On Equity
-98.1
N/A
-10.87
-0.5
N/A
-7.36
N/A
N/A
-6.84
N/A
Bond Positions Weight
N/A
N/A
N/A
N/A
N/A
N/A
97.03
N/A
N/A
N/A
Holdings Turnover
N/A
N/A
N/A
N/A
N/A
N/A
30.71
N/A
N/A
N/A
Return On Asset
-1.48
-16.93
-7.08
-0.0458
N/A
-1.46
N/A
N/A
-0.25
N/A
Number Of Shares Shorted
262
2.85 K
N/A
3 K
N/A
134
N/A
N/A
26.5 K
N/A
Book Value Per Share
-0.013
-0.025
4.02
4.0
N/A
-0.011
N/A
N/A
-0.007
N/A
Minimum Initial Investment
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
500
Total Asset
1.03 M
237.08 K
N/A
176.65 M
N/A
47.81 K
430.05 M
N/A
1.8 M
5.64 B
Debt To Equity
470.9
N/A
N/A
19.6
N/A
N/A
N/A
N/A
N/A
N/A
Target Price
0.73
N/A
N/A
8.0
N/A
N/A
N/A
N/A
1.15
N/A
Short Ratio
N/A
0.15
N/A
0.06
N/A
0.06
N/A
N/A
0.01
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
0.065
N/A
N/A
N/A
Shares Owned By Institutions
N/A
14.74
N/A
31.74
N/A
N/A
N/A
N/A
N/A
N/A
Market Capitalization
16.82 M
25.43 M
48.83 M
5.92 M
N/A
641.72 K
N/A
N/A
11.77 M
N/A
Price To Earning
N/A
N/A
4.03
27.72
N/A
-0.45
N/A
N/A
N/A
N/A
Price To Sales
456.22
1428.73
-8.15
0.11
N/A
N/A
N/A
N/A
1.59
N/A
Net Income
(2.54 M)
(2.04 M)
(7.51 M)
(12.15 M)
N/A
(296.1 K)
N/A
N/A
(1.81 M)
N/A
Earnings Per Share
-0.01
-0.02
-0.45
-4.65
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Insiders
10.64
31.83
N/A
32.41
N/A
12.06
N/A
N/A
42.24
N/A
Revenue
34.78 K
N/A
(5.99 M)
69.55 M
N/A
N/A
N/A
N/A
7.47 M
N/A
Working Capital
(843.55 K)
(2.37 M)
N/A
N/A
N/A
(666.97 K)
N/A
N/A
(2.31 M)
N/A
Ten Year Return
N/A
N/A
N/A
N/A
N/A
N/A
3.4
N/A
N/A
N/A
Cash And Equivalents
376.43 K
220.71 K
61.09 M
7.24 M
N/A
17.84 K
N/A
N/A
403.2 K
N/A
Cash Per Share
N/A
N/A
4.03
10.56
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
621.75 K
(195.5 K)
(5.99 M)
8.19 M
N/A
N/A
N/A
N/A
663.58 K
N/A
Day Typical Price
0.065
0.13
2.67
1.06
30.15
0.01
19.63
10.71
0.04
27.11
Accumulation Distribution
N/A
16357.14
0.0037
N/A
N/A
N/A
48.98
0.0259
N/A
N/A
Market Facilitation Index
N/A
N/A
0.01
N/A
N/A
N/A
0.0
0.28
N/A
N/A
Daily Balance Of Power
9.2 T
(1.00)
(1.00)
(9,223,372,036,855)
9.2 T
(9,223,372,036,855)
1.0
0.8929
(9,223,372,036,855)
(9,223,372,036,855)
Period Momentum Indicator
0.005
(0.02)
(0.01)
(0.04)
0.01
(0.01)
0.05
0.25
(0.01)
(0.43)
Rate Of Daily Change
1.08
0.86
1.0
0.96
1.0
0.5
1.0
1.02
0.8
0.98
Day Median Price
0.065
0.13
2.67
1.06
30.15
0.01
19.63
10.66
0.04
27.11
Price Action Indicator
0.0025
(0.02)
N/A
(0.02)
0.005
(0.01)
0.03
0.27
(0.01)
(0.21)
Relative Strength Index
48.97
47.89
72.61
36.81
34.63
56.07
53.65
56.73
52.94
79.44
Coefficient Of Variation
859.17
757.76
873.9
(1,651)
4433.51
812.4
752.3
1838.86
45365.56
1268.93
Mean Deviation
11.06
7.79
0.9048
5.29
0.1526
14.58
0.2025
0.8478
5.9
0.6074
Jensen Alpha
1.63
1.28
0.1349
(0.68)
(0)
4.23
0.0247
0.0338
0.0676
0.0556
Total Risk Alpha
0.6743
0.5957
0.0447
(1.42)
(0.03)
1.53
0.0046
(0.03)
(0.82)
(0.01)
Sortino Ratio
0.1346
0.1066
0.071
N/A
(0.08)
N/A
(0.14)
0.0023
(0)
(0.0006)
Downside Variance
173.42
146.81
1.46
N/A
0.4675
N/A
0.0571
3.26
417.28
0.8576
Standard Deviation
15.8
10.28
1.32
10.55
0.364
30.77
0.2434
1.28
11.46
0.8244
Kurtosis
2.2
0.8256
1.7
6.23
13.06
5.71
(0.64)
1.48
1.09
1.1
Potential Upside
40.0
18.18
3.08
15.97
0.4568
100.0
0.4651
2.13
25.0
1.24
Treynor Ratio
0.5065
1.08
1.23
(1.05)
(0.05)
(0.46)
(0.53)
0.1282
(0.02)
(5.19)
Maximum Drawdown
84.92
53.36
6.35
60.46
3.34
150.0
0.9669
6.96
45.0
3.72
Variance
249.52
105.77
1.75
111.34
0.1325
946.97
0.0593
1.64
131.24
0.6796
Market Risk Adjusted Performance
0.5165
1.09
1.24
(1.04)
(0.04)
(0.45)
(0.52)
0.1382
(0.01)
(5.18)
Risk Adjusted Performance
0.098
0.1096
0.0913
(0.04)
0.0063
0.1033
0.0798
0.0454
0.011
0.0607
Skewness
1.29
0.46
1.03
(0.29)
0.0376
2.0
0.037
(0.39)
0.4587
(0.47)
Semi Deviation
9.01
7.81
0.7477
N/A
0.2723
N/A
0.0895
1.16
8.12
0.8539
Information Ratio
0.1122
0.1256
0.0649
(0.07)
(0.16)
0.121
(0.14)
0.0032
(0)
(0.0007)
Value At Risk
(18.18)
(15.00)
(1.87)
(22.22)
(0.46)
(50.00)
(0.31)
(2.76)
(20.00)
(1.56)
Expected Short fall
(23.31)
(11.64)
(1.64)
N/A
(0.37)
N/A
(0.26)
(1.15)
(24.38)
(0.59)
Downside Deviation
13.17
12.12
1.21
N/A
0.6837
N/A
0.239
1.8
20.43
0.9261
Semi Variance
81.22
61.0
0.5591
N/A
0.0741
N/A
0.008
1.35
65.86
0.7291

Sirona Biochem Competition Performance Charts

Five steps to successful analysis of Sirona Biochem Competition

Sirona Biochem's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Sirona Biochem Corp in relation to its competition. Sirona Biochem's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Sirona Biochem in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Sirona Biochem's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Sirona Biochem Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Sirona Biochem position

In addition to having Sirona Biochem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recreation Thematic Idea Now

Recreation
Recreation Theme
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Sirona Stock Analysis

When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY